209 related articles for article (PubMed ID: 35705430)
21. Hereditary Transthyretin Amyloidosis Cardiomyopathy: The South Florida Experience.
Trujillo L; Colombo R
Am J Cardiol; 2022 Oct; 180():140-148. PubMed ID: 35945038
[TBL] [Abstract][Full Text] [Related]
22. Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis.
Ioannou A; Nitsche C; Porcari A; Patel RK; Razvi Y; Rauf MU; Martinez-Naharro A; Venneri L; Accietto A; Netti L; Bandera F; Virsinskaite R; Kotecha T; Knight D; Petrie A; Whelan C; Wechalekar A; Lachmann H; Hawkins PN; Gillmore JD; Fontana M
J Am Heart Assoc; 2024 Feb; 13(4):e033094. PubMed ID: 38314569
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in transthyretin cardiac amyloidosis.
Aimo A; Panichella G; Garofalo M; Gasparini S; Arzilli C; Castiglione V; Vergaro G; Emdin M; Maffei S
Heart Fail Rev; 2024 Mar; 29(2):321-330. PubMed ID: 37566193
[TBL] [Abstract][Full Text] [Related]
24. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
Davies DR; Redfield MM; Scott CG; Minamisawa M; Grogan M; Dispenzieri A; Chareonthaitawee P; Shah AM; Shah SJ; Wehbe RM; Solomon SD; Reddy YNV; Borlaug BA; AbouEzzeddine OF
JAMA Cardiol; 2022 Oct; 7(10):1036-1044. PubMed ID: 36069809
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
Lohrmann G; Pipilas A; Mussinelli R; Gopal DM; Berk JL; Connors LH; Vellanki N; Hellawell J; Siddiqi OK; Fox J; Maurer MS; Ruberg FL
J Card Fail; 2020 Sep; 26(9):753-759. PubMed ID: 31805416
[TBL] [Abstract][Full Text] [Related]
26. Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years.
Ioannou A; Patel RK; Razvi Y; Porcari A; Sinagra G; Venneri L; Bandera F; Masi A; Williams GE; O'Beara S; Ganesananthan S; Massa P; Knight D; Martinez-Naharro A; Kotecha T; Chacko L; Brown J; Rauf MU; Manisty C; Moon J; Lachmann H; Wechelakar A; Petrie A; Whelan C; Hawkins PN; Gillmore JD; Fontana M
Circulation; 2022 Nov; 146(22):1657-1670. PubMed ID: 36325894
[TBL] [Abstract][Full Text] [Related]
27. DISCOVERY: prevalence of transthyretin (
Akinboboye O; Shah K; Warner AL; Damy T; Taylor HA; Gollob J; Powell C; Karsten V; Vest J; Maurer MS
Amyloid; 2020 Dec; 27(4):223-230. PubMed ID: 32456532
[TBL] [Abstract][Full Text] [Related]
28. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
[TBL] [Abstract][Full Text] [Related]
30. ATTR Epidemiology, Genetics, and Prognostic Factors.
Obi CA; Mostertz WC; Griffin JM; Judge DP
Methodist Debakey Cardiovasc J; 2022; 18(2):17-26. PubMed ID: 35414855
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
[TBL] [Abstract][Full Text] [Related]
32. Comparative Outcomes of a Transthyretin Amyloid Cardiomyopathy Cohort Versus Patients With Heart Failure With Preserved Ejection Fraction Enrolled in the TOPCAT Trial.
Kim MM; Prasad M; Burton Y; Kolseth CM; Zhao Y; Chandrashekar P; Nazer B; Masri A
J Am Heart Assoc; 2023 Aug; 12(15):e029705. PubMed ID: 37522238
[TBL] [Abstract][Full Text] [Related]
33. Hereditary ATTR amyloidosis: a single-institution experience with 266 patients.
Swiecicki PL; Zhen DB; Mauermann ML; Kyle RA; Zeldenrust SR; Grogan M; Dispenzieri A; Gertz MA
Amyloid; 2015; 22(2):123-31. PubMed ID: 26017327
[TBL] [Abstract][Full Text] [Related]
34. Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.
Henein MY; Pilebro B; Lindqvist P
Heart Vessels; 2022 Sep; 37(9):1562-1569. PubMed ID: 35275264
[TBL] [Abstract][Full Text] [Related]
35. Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis.
Asif T; Vij A; Radzik B; Stern H; Simples P; Ghadiali Q; Malhotra S
J Nucl Cardiol; 2023 Apr; 30(2):792-799. PubMed ID: 34873643
[TBL] [Abstract][Full Text] [Related]
36. Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis.
Zhen DB; Swiecicki PL; Zeldenrust SR; Dispenzieri A; Mauermann ML; Gertz MA
Clin Genet; 2015 Oct; 88(4):396-400. PubMed ID: 25211232
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
[TBL] [Abstract][Full Text] [Related]
38. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
[TBL] [Abstract][Full Text] [Related]
39. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis.
Khedraki R; Saef J; Martens P; Martyn T; Sul L; Hachamovitch R; Ives L; Estep JD; Tang WHW; Hanna M
Am J Cardiol; 2024 Apr; 216():66-76. PubMed ID: 38278432
[TBL] [Abstract][Full Text] [Related]
40. Multimodality assessments of wild-type transthyretin cardiac amyloidosis with no ventricular hypertrophy.
Iwaya T; Okada A; Tateishi E; Ohta Y; Morita Y; Ohta-Ogo K; Izumi C
ESC Heart Fail; 2023 Apr; 10(2):1412-1417. PubMed ID: 36335980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
